Mackenzie Financial »

Keros Therapeutics shares owned by Mackenzie Financial

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $898k 57k 15.82
2025-06-30 $719k 54k 13.35

More positions owned by Mackenzie Financial

Rbc Cad (RY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Toronto Dominion Bk Ont Com New (TD)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Agnico (AEM)
Shopify Cl A Sub Vtg Shs (SHOP)
Bank Of Montreal Cadcom (BMO)
Canadian Pacific Kansas City (CP)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Waste Connections (WCN)
Meta Platforms Cl A (META)

View all positions for Mackenzie Financial

Top funds holding Keros Therapeutics

ADAR1 Capital Management
Vanguard Group
BlackRock
Madison Avenue Partners
Western Standard
Nantahala Capital Management
Tang Capital Management
D. E. Shaw & Co
Goldman Sachs Group
State Street Corporation
OrbiMed Advisors
Morgan Stanley
Alkeon Capital Management
Logos Global Management
Geode Capital Management

View all funds holding Keros Therapeutics